Global Analgesics Market Size, Share & Industry Trends Analysis Report By Type (Non-opioids and Opioids), By Route of Administration (Oral, Transdermal, Intravenous, Topical, and Rectal), By Regional Outlook and Forecast, 2022 - 2028

The Global Analgesics Market size is expected to reach $42.6 billion by 2028, rising at a market growth of 6.6% CAGR during the forecast period.

Analgesics, or painkillers, are drugs that are used to cure and relieve pain in the body. They are utilized when the suffering is extreme and the patient can no longer take it. Opioids, non-opioids, and compound analgesics (a mix of opioids and non-opioids) are the most often used topical analgesics worldwide. The most powerful painkillers are opioid medicines, which are developed from opium. They're only available with a prescription and are usually utilized to treat moderate to severe pain. Non-opioid drugs, on the other hand, are made out of acetaminophen rather than opium. NSAIDs (non-steroidal anti-inflammatory medicines) are another class of treatments often used to relieve mild to moderate pain.

Increased rates of chronic diseases, such as tuberculosis, cardiovascular disorders, cancer, and arthritis are driving the expansion of the analgesics market. In addition, infectious disorders, such as respiratory, gastrointestinal, and neurological disorders are causing a significant increase in the number of patients. As the prevalence of these disorders rises, so does the demand for painkillers, which is predicted to drive the analgesics market share even higher. Additionally, an increase in investment from commercial and government organizations for the production of drug manufacturing segments, as well as an increase in R&D activities for the innovation of analgesic goods, has boosted the growth of the analgesics market. According to the World Health Organization, AIDS and malaria cost the lives of nearly 1.5 million people worldwide in 2020. Tuberculosis affects ten million people each year. Despite the fact that tuberculosis is a preventable and treatable infection, 1.5 million people die from it each year, making it the leading infectious killer on the planet. Analgesics, which primarily contain opioid medications, are also in high demand due to cardiovascular illnesses and cancer.

Furthermore, the analgesics market is expected to develop due to an increase in the number of clinical tests being conducted to assess the safety and efficacy of a vast variety of therapeutic medications. Furthermore, an increase in the elderly population, as well as cardiovascular disorders, cancer, and arthritis, is a crucial component driving analgesics market trends. The aging population also has more regular concerns with pain and aches, which helps the industry grow. Furthermore, technical advancements in the pharma companies to create advanced analgesic pharmaceuticals are likely to provide lucrative prospects for the analgesic market in the coming years. Furthermore, the prevalence of major manufacturing businesses that manufacture and sell analgesic pharmaceuticals, rising demand for over-the-counter drugs, and rising healthcare spending all contribute to the market's growth.

COVID-19 Impact Analysis

The COVID-19 pandemic had a severe impact on various economies all over the world. Numerous businesses across the world were significantly demolished by the effect of the pandemic. In addition, governments all over the world were compelled to impose lockdown in their nations in order to regulate the diffusion of the COVID-19 infection. This lockdown scenario not only devastated various industries but also disrupted the worldwide supply chain of all the products and services. However, the healthcare sector observed a significant incline in the demand for its services during the COVID-19 outbreak. There was a substantial patient pool in hospitals amid the pandemic. Moreover, a considerable number of people suffered chronic pain in their chest as a result of the side effects of the virus.

Market Growth Factors

Rising incidences of chronic pain across the world

Physical pain is a prevalent problem all around the world. According to NCBI5, 20% of people all over the world suffer from some form of physical pain, with 10% of those identified with chronic pain for the first time each year. However, the issue of pain has been mostly considered as a medical problem, with public health paying little attention to it. The prevalence, frequency, and broad-ranging social and health consequences of pain mandate that the public health system pays particular attention to it. As a result, healthcare providers, as well as public health practitioners, would have an increased understanding of pain along with the most effective public health as well as social policy solutions.

Rising demand for strong agonists

A pharmaceutical substance that activates certain brain receptors is known as an agonist. These agonists induce a robust physiological/pharmacological response even when just a limited number of receptors are activated, indicating that the medicine has high intrinsic activity. Strong agonist analgesics, including opioids, like encompass fentanyl, morphine, dihydromorphinone, oxycodone, and oxymorphone. The global health system was wrought havoc by COVID-19. During the pandemic, health organizations all over the world were aimed at regulating infection and addressing COVID-19 patients, which resulted in the suspension of elective surgeries and consultations, putting a strain on hospital and pain clinic pain services.

Market Restraining Factors

Risk of overdose and addiction

Due to the prevalence of deaths caused by drug overdose involving opioids and other analgesics remains high, researchers and governments around various countries continue to monitor opioid overdose deaths. Opioids caused about 50,000 deaths in 2019, more than six times the number of opioid-related fatal overdoses in 1999. It's crucial to determine and identify which substances are implicated in an overdose, how often they're present, and how their presence changes over time. By recognizing drug involvement, practitioners can better identify effective prevention and response activities. Overdose death data has traditionally been analyzed using the National Vital Statistics System mortality data (NVSS-M), with the combined classifications of semi-synthetic, natural, and synthetic opioids

Type Outlook

Based on Type, the market is segmented into Non-opioids and Opioids. In 2021, the opioids segment witnessed a substantia revenue share of the analgesics market. The rising growth of the segment is attributed to the rapidly rising instances of cardiovascular diseases. An increase in the rates of chronic diseases, such as tuberculosis, arthritis, and cancer is likely to fuel the growth of the opioid segment during the forecast period. In addition, the growth of the segment is also surging as opioids have anti-inflammatory, analgesic, and antipyretic properties.

Route of Administration Outlook

Based on Route of Administration, the market is segmented into Oral, Transdermal, Intravenous, Topical, and Rectal. In 2021, the oral segment procured the largest revenue share of the analgesics market. The constantly increasing growth of this segment is attributed to the fact that oral analgesic delivery is simple, non-invasive, and effective in contrast to other methods of administration. Furthermore, the expansion of the oral administration segment is fueled by an increase in the number of FDA drug approvals as well as developments in pharmaceutical R&D activities across several developed nations all over the world.

Analgesics Market Report Coverage

Report Attribute	Details
Market size value in 2021	USD 27.6 Billion
Market size forecast in 2028	USD 42.6 Billion
Base Year	2021
Historical Period	2018 to 2020
Forecast Period	2022 to 2028
Revenue Growth Rate	CAGR of 6.6% from 2022 to 2028
Number of Pages	163
Number of Tables	270
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling
Segments covered	Type, Route of Administration, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	Rising incidences of chronic pain across the world Rising demand for strong agonists
Restraints	Risk of overdose and addiction

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. In 2021, North America accounted for the largest revenue share of the analgesics market. The growth of the analgesics market across North America is attributed to the rise in demand for non-opioid medications, the presence of key players, and the expansion of R&D activities across the healthcare sector in the region. The increasing growth of the regional market is also owing to an increase in painkiller use, increased awareness about the utilization of analgesic drugs, increased healthcare expenditures, increased OTC analgesics market growth, and increased analgesics product adoption.

Free Valuable Insights: Global Analgesics Market size to reach USD 42.6 Billion by 2028

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AbbVie, Inc., Reckitt Benckiser Group PLC, Abbott Laboratories, Johnson & Johnson, Bayer AG, Endo International PLC, GlaxoSmithKline PLC, Pfizer, Inc., Sanofi S.A., and Eli Lilly And Company.

Recent Strategies Deployed in Analgesics Market

• Apr-2022: Abbott introduced a new version of its NeuroSphere myPath, a digital health app. With this launch, the company aimed to facilitate healthcare professionals to more precisely track their patients as they trial Abbott neurostimulation instruments in order to address the chronic pain issue in them. Moreover, this launch would also complement the connected care technology portfolio of the company.
• Jan-2022: Eli Lilly expanded its geographical footprint in North Carolina with the introduction of its new manufacturing facility. With this geographical expansion, the company would manufacture injectable devices and products while also expanding its manufacturing capacity of the company.
• Jun-2021: Bayer expanded its business in India with the establishment of its Consumer Health division. The company aimed to strengthen its footprint across the Indian market while also complementing its Crop Science and Pharmaceuticals divisions. In addition, the company would also utilize digital prospects across the whole value chain in order to scale access to healthcare and customized self-care solutions.
• Jan-2021: Eli Lilli and co. came into a licensing agreement with Asahi Kasei Pharma, a Japanese pharmaceutical company. Through this agreement, the companies aimed to focus on the development and commercialization of a solution to address chronic pain and neuroinflammatory pain conditions.
• Jan-2021: Pfizer partnered with Premier, an American healthcare improvement company. Following this partnership, the companies would offer five essential medications to healthcare practitioners in order to assist them in fulfilling the long-term and immediate demands for medications essential to a range of patient care interventions.
• Nov-2020: Abbott launched IonicRF Generator, a novel US FDA-approved device. The new product aimed to offer non-surgical and minimally invasive treatment to patients with nervous system pain. In addition, the new radiofrequency ablation device leverages heat to target particular nerves and restricts pain signals from reaching the brain.
• Mar-2020: Eli Lilly and Company teamed up with Pfizer, an American multinational pharmaceutical and biotechnology corporation. With this collaboration, the companies aimed to increase their efforts for the US FDA approval for a Biologics License Application for its tanezumab 2.5 administered subcutaneously for patients with chronic pain.
• Sep-2019: Abbott received the US FDA approval for its Proclaim XR, a recharge-free neurostimulation system. The new product would deliver a low dose of proprietary BurstDR of Abbott. The new product aimed to work by utilizing low doses of mild electrical pulses in order to change pain signals while they transmit from the spinal cord to the brain.
• Sep-2019: Reckitt Benckiser unveiled a novel Diclofenac range of Moov with the enhanced formulation. Through this launch, the company aimed to strengthen its footprint in the pain relief OTC products market.
• Nov-2018: Abbott rolled out its new DRG Invisible Trial System, a US FDA and grant of the European CE-Mark approved CPM system. The new product is a non-opioid treatment option, which provides dorsal root ganglion stimulation of the company and allows patients to test before using a device implant.
• Sep-2018: GlaxoSmithKline expanded its geographical footprint in Canada with the introduction of a manufacturing unit. Under this geographical expansion, the company aimed to manufacture an over-the-counter pain reliever.
• Jul-2018: AbbVie along with Neurocrine Biosciences received the US FDA approval of ORILISSA, an oral gonadotropin-releasing hormone antagonist. This approval would complement AbbVie's vision to address critical diseases along with unmet demands.
• Jan-2018: GlaxoSmithKline collaborated with NeuroMetrix, a developer of non-invasive medical devices. Following this collaboration, the companies aimed to focus on GSK Consumer Healthcare to increase access to Quell technology among chronic pain patients around the world.

Scope of the Study

Market Segments Covered in the Report:

By Type

• Non-opioids
• Opioids

By Route of Administration

• Oral
• Transdermal
• Intravenous
• Topical
• Rectal

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• AbbVie, Inc.
• Reckitt Benckiser Group PLC
• Abbott Laboratories
• Johnson & Johnson
• Bayer AG
• Endo International PLC
• GlaxoSmithKline PLC
• Pfizer, Inc.
• Sanofi S.A.
• Eli Lilly And Company

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Analgesics Market, by Type
1.4.2 Global Analgesics Market, by Route of Administration
1.4.3 Global Analgesics Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies deployed in Analgesics Market

Chapter 4. Global Analgesics Market by Type
4.1 Global Macro processing Market by Region
4.2 Global Micro processing Market by Region

Chapter 5. Global Analgesics Market by Route of Administration
5.1 Global Oral Market by Region
5.2 Global Transdermal Market by Region
5.3 Global Intravenous Market by Region
5.4 Global Topical Market by Region
5.5 Global Rectal Market by Region

Chapter 6. Global Analgesics Market by Region
6.1 North America Analgesics Market
6.1.1 North America Analgesics Market by Type
6.1.1.1 North America Macro processing Market by Country
6.1.1.2 North America Micro processing Market by Country
6.1.2 North America Analgesics Market by Route of Administration
6.1.2.1 North America Oral Market by Country
6.1.2.2 North America Transdermal Market by Country
6.1.2.3 North America Intravenous Market by Country
6.1.2.4 North America Topical Market by Country
6.1.2.5 North America Rectal Market by Country
6.1.3 North America Analgesics Market by Country
6.1.3.1 US Analgesics Market
6.1.3.1.1 US Analgesics Market by Type
6.1.3.1.2 US Analgesics Market by Route of Administration
6.1.3.2 Canada Analgesics Market
6.1.3.2.1 Canada Analgesics Market by Type
6.1.3.2.2 Canada Analgesics Market by Route of Administration
6.1.3.3 Mexico Analgesics Market
6.1.3.3.1 Mexico Analgesics Market by Type
6.1.3.3.2 Mexico Analgesics Market by Route of Administration
6.1.3.4 Rest of North America Analgesics Market
6.1.3.4.1 Rest of North America Analgesics Market by Type
6.1.3.4.2 Rest of North America Analgesics Market by Route of Administration
6.2 Europe Analgesics Market
6.2.1 Europe Analgesics Market by Type
6.2.1.1 Europe Macro processing Market by Country
6.2.1.2 Europe Micro processing Market by Country
6.2.2 Europe Analgesics Market by Route of Administration
6.2.2.1 Europe Oral Market by Country
6.2.2.2 Europe Transdermal Market by Country
6.2.2.3 Europe Intravenous Market by Country
6.2.2.4 Europe Topical Market by Country
6.2.2.5 Europe Rectal Market by Country
6.2.3 Europe Analgesics Market by Country
6.2.3.1 Germany Analgesics Market
6.2.3.1.1 Germany Analgesics Market by Type
6.2.3.1.2 Germany Analgesics Market by Route of Administration
6.2.3.2 UK Analgesics Market
6.2.3.2.1 UK Analgesics Market by Type
6.2.3.2.2 UK Analgesics Market by Route of Administration
6.2.3.3 France Analgesics Market
6.2.3.3.1 France Analgesics Market by Type
6.2.3.3.2 France Analgesics Market by Route of Administration
6.2.3.4 Russia Analgesics Market
6.2.3.4.1 Russia Analgesics Market by Type
6.2.3.4.2 Russia Analgesics Market by Route of Administration
6.2.3.5 Spain Analgesics Market
6.2.3.5.1 Spain Analgesics Market by Type
6.2.3.5.2 Spain Analgesics Market by Route of Administration
6.2.3.6 Italy Analgesics Market
6.2.3.6.1 Italy Analgesics Market by Type
6.2.3.6.2 Italy Analgesics Market by Route of Administration
6.2.3.7 Rest of Europe Analgesics Market
6.2.3.7.1 Rest of Europe Analgesics Market by Type
6.2.3.7.2 Rest of Europe Analgesics Market by Route of Administration
6.3 Asia Pacific Analgesics Market
6.3.1 Asia Pacific Analgesics Market by Type
6.3.1.1 Asia Pacific Macro processing Market by Country
6.3.1.2 Asia Pacific Micro processing Market by Country
6.3.2 Asia Pacific Analgesics Market by Route of Administration
6.3.2.1 Asia Pacific Oral Market by Country
6.3.2.2 Asia Pacific Transdermal Market by Country
6.3.2.3 Asia Pacific Intravenous Market by Country
6.3.2.4 Asia Pacific Topical Market by Country
6.3.2.5 Asia Pacific Rectal Market by Country
6.3.3 Asia Pacific Analgesics Market by Country
6.3.3.1 China Analgesics Market
6.3.3.1.1 China Analgesics Market by Type
6.3.3.1.2 China Analgesics Market by Route of Administration
6.3.3.2 Japan Analgesics Market
6.3.3.2.1 Japan Analgesics Market by Type
6.3.3.2.2 Japan Analgesics Market by Route of Administration
6.3.3.3 India Analgesics Market
6.3.3.3.1 India Analgesics Market by Type
6.3.3.3.2 India Analgesics Market by Route of Administration
6.3.3.4 South Korea Analgesics Market
6.3.3.4.1 South Korea Analgesics Market by Type
6.3.3.4.2 South Korea Analgesics Market by Route of Administration
6.3.3.5 Singapore Analgesics Market
6.3.3.5.1 Singapore Analgesics Market by Type
6.3.3.5.2 Singapore Analgesics Market by Route of Administration
6.3.3.6 Malaysia Analgesics Market
6.3.3.6.1 Malaysia Analgesics Market by Type
6.3.3.6.2 Malaysia Analgesics Market by Route of Administration
6.3.3.7 Rest of Asia Pacific Analgesics Market
6.3.3.7.1 Rest of Asia Pacific Analgesics Market by Type
6.3.3.7.2 Rest of Asia Pacific Analgesics Market by Route of Administration
6.4 LAMEA Analgesics Market
6.4.1 LAMEA Analgesics Market by Type
6.4.1.1 LAMEA Macro processing Market by Country
6.4.1.2 LAMEA Micro processing Market by Country
6.4.2 LAMEA Analgesics Market by Route of Administration
6.4.2.1 LAMEA Oral Market by Country
6.4.2.2 LAMEA Transdermal Market by Country
6.4.2.3 LAMEA Intravenous Market by Country
6.4.2.4 LAMEA Topical Market by Country
6.4.2.5 LAMEA Rectal Market by Country
6.4.3 LAMEA Analgesics Market by Country
6.4.3.1 Brazil Analgesics Market
6.4.3.1.1 Brazil Analgesics Market by Type
6.4.3.1.2 Brazil Analgesics Market by Route of Administration
6.4.3.2 Argentina Analgesics Market
6.4.3.2.1 Argentina Analgesics Market by Type
6.4.3.2.2 Argentina Analgesics Market by Route of Administration
6.4.3.3 UAE Analgesics Market
6.4.3.3.1 UAE Analgesics Market by Type
6.4.3.3.2 UAE Analgesics Market by Route of Administration
6.4.3.4 Saudi Arabia Analgesics Market
6.4.3.4.1 Saudi Arabia Analgesics Market by Type
6.4.3.4.2 Saudi Arabia Analgesics Market by Route of Administration
6.4.3.5 South Africa Analgesics Market
6.4.3.5.1 South Africa Analgesics Market by Type
6.4.3.5.2 South Africa Analgesics Market by Route of Administration
6.4.3.6 Nigeria Analgesics Market
6.4.3.6.1 Nigeria Analgesics Market by Type
6.4.3.6.2 Nigeria Analgesics Market by Route of Administration
6.4.3.7 Rest of LAMEA Analgesics Market
6.4.3.7.1 Rest of LAMEA Analgesics Market by Type
6.4.3.7.2 Rest of LAMEA Analgesics Market by Route of Administration

Chapter 7. Company Profiles
7.1 AbbVie, Inc. (Allergan PLC)
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Approvals and Trials:
7.2 Reckitt Benckiser Group PLC
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Product Launches and Product Expansions:
7.3 Abbott Laboratories
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.3.5.2 Approvals and Trials:
7.4 Johnson & Johnson
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental &Regional Analysis
7.4.4 Research & Development Expenses
7.5 Bayer AG
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Product Launches and Product Expansions:
7.6 Endo International PLC
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.7 GlaxoSmithKline PLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Partnerships, Collaborations, and Agreements:
7.7.5.2 Geographical Expansions:
7.8 Pfizer, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional & Segmental Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Partnerships, Collaborations, and Agreements:
7.9 Sanofi S.A.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.10. Eli Lilly And Company
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional Analysis
7.10.4 Research & Development Expenses
7.10.5 Recent strategies and developments:
7.10.5.1 Partnerships, Collaborations, and Agreements:
7.10.5.2 Geographical Expansions:

TABLE 1 Global Analgesics Market, 2018 - 2021, USD Million
TABLE 2 Global Analgesics Market, 2022 - 2028, USD Million
TABLE 3 Global Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 4 Global Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 5 Global Macro processing Market by Region, 2018 - 2021, USD Million
TABLE 6 Global Macro processing Market by Region, 2022 - 2028, USD Million
TABLE 7 Global Micro processing Market by Region, 2018 - 2021, USD Million
TABLE 8 Global Micro processing Market by Region, 2022 - 2028, USD Million
TABLE 9 Global Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 10 Global Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 11 Global Oral Market by Region, 2018 - 2021, USD Million
TABLE 12 Global Oral Market by Region, 2022 - 2028, USD Million
TABLE 13 Global Transdermal Market by Region, 2018 - 2021, USD Million
TABLE 14 Global Transdermal Market by Region, 2022 - 2028, USD Million
TABLE 15 Global Intravenous Market by Region, 2018 - 2021, USD Million
TABLE 16 Global Intravenous Market by Region, 2022 - 2028, USD Million
TABLE 17 Global Topical Market by Region, 2018 - 2021, USD Million
TABLE 18 Global Topical Market by Region, 2022 - 2028, USD Million
TABLE 19 Global Rectal Market by Region, 2018 - 2021, USD Million
TABLE 20 Global Rectal Market by Region, 2022 - 2028, USD Million
TABLE 21 Global Analgesics Market by Region, 2018 - 2021, USD Million
TABLE 22 Global Analgesics Market by Region, 2022 - 2028, USD Million
TABLE 23 North America Analgesics Market, 2018 - 2021, USD Million
TABLE 24 North America Analgesics Market, 2022 - 2028, USD Million
TABLE 25 North America Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 26 North America Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 27 North America Macro processing Market by Country, 2018 - 2021, USD Million
TABLE 28 North America Macro processing Market by Country, 2022 - 2028, USD Million
TABLE 29 North America Micro processing Market by Country, 2018 - 2021, USD Million
TABLE 30 North America Micro processing Market by Country, 2022 - 2028, USD Million
TABLE 31 North America Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 32 North America Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 33 North America Oral Market by Country, 2018 - 2021, USD Million
TABLE 34 North America Oral Market by Country, 2022 - 2028, USD Million
TABLE 35 North America Transdermal Market by Country, 2018 - 2021, USD Million
TABLE 36 North America Transdermal Market by Country, 2022 - 2028, USD Million
TABLE 37 North America Intravenous Market by Country, 2018 - 2021, USD Million
TABLE 38 North America Intravenous Market by Country, 2022 - 2028, USD Million
TABLE 39 North America Topical Market by Country, 2018 - 2021, USD Million
TABLE 40 North America Topical Market by Country, 2022 - 2028, USD Million
TABLE 41 North America Rectal Market by Country, 2018 - 2021, USD Million
TABLE 42 North America Rectal Market by Country, 2022 - 2028, USD Million
TABLE 43 North America Analgesics Market by Country, 2018 - 2021, USD Million
TABLE 44 North America Analgesics Market by Country, 2022 - 2028, USD Million
TABLE 45 US Analgesics Market, 2018 - 2021, USD Million
TABLE 46 US Analgesics Market, 2022 - 2028, USD Million
TABLE 47 US Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 48 US Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 49 US Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 50 US Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 51 Canada Analgesics Market, 2018 - 2021, USD Million
TABLE 52 Canada Analgesics Market, 2022 - 2028, USD Million
TABLE 53 Canada Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 54 Canada Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 55 Canada Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 56 Canada Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 57 Mexico Analgesics Market, 2018 - 2021, USD Million
TABLE 58 Mexico Analgesics Market, 2022 - 2028, USD Million
TABLE 59 Mexico Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 60 Mexico Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 61 Mexico Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 62 Mexico Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 63 Rest of North America Analgesics Market, 2018 - 2021, USD Million
TABLE 64 Rest of North America Analgesics Market, 2022 - 2028, USD Million
TABLE 65 Rest of North America Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 66 Rest of North America Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 67 Rest of North America Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 68 Rest of North America Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 69 Europe Analgesics Market, 2018 - 2021, USD Million
TABLE 70 Europe Analgesics Market, 2022 - 2028, USD Million
TABLE 71 Europe Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 72 Europe Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 73 Europe Macro processing Market by Country, 2018 - 2021, USD Million
TABLE 74 Europe Macro processing Market by Country, 2022 - 2028, USD Million
TABLE 75 Europe Micro processing Market by Country, 2018 - 2021, USD Million
TABLE 76 Europe Micro processing Market by Country, 2022 - 2028, USD Million
TABLE 77 Europe Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 78 Europe Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 79 Europe Oral Market by Country, 2018 - 2021, USD Million
TABLE 80 Europe Oral Market by Country, 2022 - 2028, USD Million
TABLE 81 Europe Transdermal Market by Country, 2018 - 2021, USD Million
TABLE 82 Europe Transdermal Market by Country, 2022 - 2028, USD Million
TABLE 83 Europe Intravenous Market by Country, 2018 - 2021, USD Million
TABLE 84 Europe Intravenous Market by Country, 2022 - 2028, USD Million
TABLE 85 Europe Topical Market by Country, 2018 - 2021, USD Million
TABLE 86 Europe Topical Market by Country, 2022 - 2028, USD Million
TABLE 87 Europe Rectal Market by Country, 2018 - 2021, USD Million
TABLE 88 Europe Rectal Market by Country, 2022 - 2028, USD Million
TABLE 89 Europe Analgesics Market by Country, 2018 - 2021, USD Million
TABLE 90 Europe Analgesics Market by Country, 2022 - 2028, USD Million
TABLE 91 Germany Analgesics Market, 2018 - 2021, USD Million
TABLE 92 Germany Analgesics Market, 2022 - 2028, USD Million
TABLE 93 Germany Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 94 Germany Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 95 Germany Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 96 Germany Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 97 UK Analgesics Market, 2018 - 2021, USD Million
TABLE 98 UK Analgesics Market, 2022 - 2028, USD Million
TABLE 99 UK Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 100 UK Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 101 UK Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 102 UK Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 103 France Analgesics Market, 2018 - 2021, USD Million
TABLE 104 France Analgesics Market, 2022 - 2028, USD Million
TABLE 105 France Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 106 France Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 107 France Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 108 France Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 109 Russia Analgesics Market, 2018 - 2021, USD Million
TABLE 110 Russia Analgesics Market, 2022 - 2028, USD Million
TABLE 111 Russia Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 112 Russia Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 113 Russia Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 114 Russia Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 115 Spain Analgesics Market, 2018 - 2021, USD Million
TABLE 116 Spain Analgesics Market, 2022 - 2028, USD Million
TABLE 117 Spain Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 118 Spain Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 119 Spain Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 120 Spain Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 121 Italy Analgesics Market, 2018 - 2021, USD Million
TABLE 122 Italy Analgesics Market, 2022 - 2028, USD Million
TABLE 123 Italy Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 124 Italy Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 125 Italy Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 126 Italy Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 127 Rest of Europe Analgesics Market, 2018 - 2021, USD Million
TABLE 128 Rest of Europe Analgesics Market, 2022 - 2028, USD Million
TABLE 129 Rest of Europe Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 130 Rest of Europe Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 131 Rest of Europe Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 132 Rest of Europe Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 133 Asia Pacific Analgesics Market, 2018 - 2021, USD Million
TABLE 134 Asia Pacific Analgesics Market, 2022 - 2028, USD Million
TABLE 135 Asia Pacific Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 136 Asia Pacific Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 137 Asia Pacific Macro processing Market by Country, 2018 - 2021, USD Million
TABLE 138 Asia Pacific Macro processing Market by Country, 2022 - 2028, USD Million
TABLE 139 Asia Pacific Micro processing Market by Country, 2018 - 2021, USD Million
TABLE 140 Asia Pacific Micro processing Market by Country, 2022 - 2028, USD Million
TABLE 141 Asia Pacific Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 142 Asia Pacific Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 143 Asia Pacific Oral Market by Country, 2018 - 2021, USD Million
TABLE 144 Asia Pacific Oral Market by Country, 2022 - 2028, USD Million
TABLE 145 Asia Pacific Transdermal Market by Country, 2018 - 2021, USD Million
TABLE 146 Asia Pacific Transdermal Market by Country, 2022 - 2028, USD Million
TABLE 147 Asia Pacific Intravenous Market by Country, 2018 - 2021, USD Million
TABLE 148 Asia Pacific Intravenous Market by Country, 2022 - 2028, USD Million
TABLE 149 Asia Pacific Topical Market by Country, 2018 - 2021, USD Million
TABLE 150 Asia Pacific Topical Market by Country, 2022 - 2028, USD Million
TABLE 151 Asia Pacific Rectal Market by Country, 2018 - 2021, USD Million
TABLE 152 Asia Pacific Rectal Market by Country, 2022 - 2028, USD Million
TABLE 153 Asia Pacific Analgesics Market by Country, 2018 - 2021, USD Million
TABLE 154 Asia Pacific Analgesics Market by Country, 2022 - 2028, USD Million
TABLE 155 China Analgesics Market, 2018 - 2021, USD Million
TABLE 156 China Analgesics Market, 2022 - 2028, USD Million
TABLE 157 China Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 158 China Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 159 China Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 160 China Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 161 Japan Analgesics Market, 2018 - 2021, USD Million
TABLE 162 Japan Analgesics Market, 2022 - 2028, USD Million
TABLE 163 Japan Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 164 Japan Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 165 Japan Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 166 Japan Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 167 India Analgesics Market, 2018 - 2021, USD Million
TABLE 168 India Analgesics Market, 2022 - 2028, USD Million
TABLE 169 India Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 170 India Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 171 India Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 172 India Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 173 South Korea Analgesics Market, 2018 - 2021, USD Million
TABLE 174 South Korea Analgesics Market, 2022 - 2028, USD Million
TABLE 175 South Korea Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 176 South Korea Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 177 South Korea Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 178 South Korea Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 179 Singapore Analgesics Market, 2018 - 2021, USD Million
TABLE 180 Singapore Analgesics Market, 2022 - 2028, USD Million
TABLE 181 Singapore Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 182 Singapore Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 183 Singapore Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 184 Singapore Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 185 Malaysia Analgesics Market, 2018 - 2021, USD Million
TABLE 186 Malaysia Analgesics Market, 2022 - 2028, USD Million
TABLE 187 Malaysia Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 188 Malaysia Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 189 Malaysia Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 190 Malaysia Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 191 Rest of Asia Pacific Analgesics Market, 2018 - 2021, USD Million
TABLE 192 Rest of Asia Pacific Analgesics Market, 2022 - 2028, USD Million
TABLE 193 Rest of Asia Pacific Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 194 Rest of Asia Pacific Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 195 Rest of Asia Pacific Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 196 Rest of Asia Pacific Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 197 LAMEA Analgesics Market, 2018 - 2021, USD Million
TABLE 198 LAMEA Analgesics Market, 2022 - 2028, USD Million
TABLE 199 LAMEA Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 200 LAMEA Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 201 LAMEA Macro processing Market by Country, 2018 - 2021, USD Million
TABLE 202 LAMEA Macro processing Market by Country, 2022 - 2028, USD Million
TABLE 203 LAMEA Micro processing Market by Country, 2018 - 2021, USD Million
TABLE 204 LAMEA Micro processing Market by Country, 2022 - 2028, USD Million
TABLE 205 LAMEA Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 206 LAMEA Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 207 LAMEA Oral Market by Country, 2018 - 2021, USD Million
TABLE 208 LAMEA Oral Market by Country, 2022 - 2028, USD Million
TABLE 209 LAMEA Transdermal Market by Country, 2018 - 2021, USD Million
TABLE 210 LAMEA Transdermal Market by Country, 2022 - 2028, USD Million
TABLE 211 LAMEA Intravenous Market by Country, 2018 - 2021, USD Million
TABLE 212 LAMEA Intravenous Market by Country, 2022 - 2028, USD Million
TABLE 213 LAMEA Topical Market by Country, 2018 - 2021, USD Million
TABLE 214 LAMEA Topical Market by Country, 2022 - 2028, USD Million
TABLE 215 LAMEA Rectal Market by Country, 2018 - 2021, USD Million
TABLE 216 LAMEA Rectal Market by Country, 2022 - 2028, USD Million
TABLE 217 LAMEA Analgesics Market by Country, 2018 - 2021, USD Million
TABLE 218 LAMEA Analgesics Market by Country, 2022 - 2028, USD Million
TABLE 219 Brazil Analgesics Market, 2018 - 2021, USD Million
TABLE 220 Brazil Analgesics Market, 2022 - 2028, USD Million
TABLE 221 Brazil Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 222 Brazil Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 223 Brazil Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 224 Brazil Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 225 Argentina Analgesics Market, 2018 - 2021, USD Million
TABLE 226 Argentina Analgesics Market, 2022 - 2028, USD Million
TABLE 227 Argentina Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 228 Argentina Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 229 Argentina Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 230 Argentina Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 231 UAE Analgesics Market, 2018 - 2021, USD Million
TABLE 232 UAE Analgesics Market, 2022 - 2028, USD Million
TABLE 233 UAE Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 234 UAE Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 235 UAE Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 236 UAE Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 237 Saudi Arabia Analgesics Market, 2018 - 2021, USD Million
TABLE 238 Saudi Arabia Analgesics Market, 2022 - 2028, USD Million
TABLE 239 Saudi Arabia Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 240 Saudi Arabia Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 241 Saudi Arabia Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 242 Saudi Arabia Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 243 South Africa Analgesics Market, 2018 - 2021, USD Million
TABLE 244 South Africa Analgesics Market, 2022 - 2028, USD Million
TABLE 245 South Africa Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 246 South Africa Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 247 South Africa Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 248 South Africa Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 249 Nigeria Analgesics Market, 2018 - 2021, USD Million
TABLE 250 Nigeria Analgesics Market, 2022 - 2028, USD Million
TABLE 251 Nigeria Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 252 Nigeria Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 253 Nigeria Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 254 Nigeria Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 255 Rest of LAMEA Analgesics Market, 2018 - 2021, USD Million
TABLE 256 Rest of LAMEA Analgesics Market, 2022 - 2028, USD Million
TABLE 257 Rest of LAMEA Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 258 Rest of LAMEA Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 259 Rest of LAMEA Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 260 Rest of LAMEA Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 261 Key information – AbbVie, Inc.
TABLE 262 Key information – Reckitt Benckiser Group PLC
TABLE 263 Key Information – Abbott Laboratories
TABLE 264 Key information – Johnson & Johnson
TABLE 265 Key Information – Bayer AG
TABLE 266 Key Information – Endo International PLC
TABLE 267 Key Information – GlaxoSmithKline PLC
TABLE 268 Key Information – Pfizer, Inc.
TABLE 269 Key Information – Sanofi S.A.
TABLE 270 Key Information – Eli Lilly And Company

List of Figures
FIG 1 Methodology for the research
FIG 2 Global Analgesics Market Share by Type, 2021
FIG 3 Global Analgesics Market Share by Type, 2028
FIG 4 Global Analgesics Market by Type, 2018 - 2028, USD Million
FIG 5 Global Analgesics Market Share by Route of Administration, 2021
FIG 6 Global Analgesics Market Share by Route of Administration, 2028
FIG 7 Global Analgesics Market by Route of Administration, 2018 - 2028, USD Million
FIG 8 Global Analgesics Market Share by Region, 2021
FIG 9 Global Analgesics Market Share by Region, 2028
FIG 10 Global Analgesics Market by Region, 2018 - 2028, USD Million
FIG 11 Recent strategies and developments: Abbott Laboratories
FIG 12 Recent strategies and developments: Eli Lilly And Company